top of page

Nanobiotix appoints new senior clinical development and investor directors

Nanobiotix, a late clinical-stage nanomedicine company, has appointed Dr Mihail Obrocea as the Head of US Clinical Development and Noel Kurdi as the Director of Investor Relations.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page